Pharmacokinetics of Ketamine in Infants and Children

ClinicalTrials.gov ID: NCT00553839

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00553839. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:28 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Dosing of medications is based on the plasma level achieved with a given dose and how long the medicine remains in the body. This study is called pharmacokinetics-that is, what the body does to the medication. Ketamine is an intravenous medication used for anesthesia and sedation in children. However the pharmacokinetics of Ketamine has not been systematically studied. We propose to study the pharmacokinetics of ketamine in different age groups of children ranging from infants to teenagers.

Study identification

NCT ID: NCT00553839
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Stanford University; Other
Enrollment: 21 participants

Conditions and interventions

Conditions

The Pk of IV Ketamine in Children With Heart Disease

Interventions

ketamine hydrochloride Drug

Drug

Eligibility (public fields only)

Age range: Up to 17 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 2007 (Type not available)
Primary completion: Jan 2009 (Actual)
Completion: Jan 2009 (Actual)
Last update posted: Feb 8, 2016

2007 – 2009

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Lucile Packard Children's Hospital	Palo Alto	California	94304	—
The Children's Hospital	Denver	Colorado	80218	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00553839, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 8, 2016 · Synced Nov 12, 2026